Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDH17 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | CES2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | CARMIL2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
mRNA | CTDSP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ECI2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | PEX3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | FGL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | STAT5B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
mRNA | COL1A2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | WDR62 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |